UBS Group »

Cara Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $27k 36k 0.74
2023-09-30 $42k 25k 1.68
2023-06-30 $102k 36k 2.83
2023-03-31 $191k 39k 4.91
2022-12-31 $650k 61k 10.74
2022-09-30 $144k 15k 9.31
2022-06-30 $90k 9.8k 9.15
2022-03-31 $196k 16k 12.44
2021-12-31 $452k 37k 12.17
2021-09-30 $198k 13k 15.41
2021-06-30 $318k 22k 14.32
2021-03-31 $408k 19k 21.71
2020-12-31 $418k 28k 15.09
2020-09-30 $262k 21k 12.70
2020-06-30 $572k 33k 17.13
2020-03-31 $538k 41k 13.23
2019-12-31 $1.3M 83k 16.08
2019-09-30 $1.0M 56k 18.28
2019-06-30 $1.9M 89k 21.49
2019-03-31 $1.3M 67k 19.63
2018-12-31 $2.6M 204k 12.99
2018-09-30 $1.5M 65k 23.96
2018-06-30 $335k 17k 19.39
2018-03-31 $2.2M 178k 12.36
2017-12-31 $474k 39k 12.22
2017-09-30 $1.5M 111k 13.69
2017-06-30 $1.5M 95k 15.39
2017-03-31 $194k 11k 18.37
2016-12-31 $85k 9.0k 9.39
2016-09-30 $9.0k 1.1k 8.57
2016-06-30 $10k 2.5k 4.00
2016-03-31 $3.0k 500 6.00
2015-12-31 $41k 2.4k 16.87
2015-09-30 $55k 3.8k 14.38
2015-03-31 $5.0k 500 10.00